NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,982,053 | +5.6% | 29,276 | +4.6% | 0.11% | +7.7% |
| Q2 2023 | $2,823,933 | +22.7% | 27,985 | +11.8% | 0.10% | +16.9% |
| Q1 2023 | $2,302,270 | +1.4% | 25,025 | +0.0% | 0.09% | -4.3% |
| Q4 2022 | $2,270,073 | +55.4% | 25,023 | +30.2% | 0.09% | +38.8% |
| Q3 2022 | $1,461,000 | +4.7% | 19,217 | +16.5% | 0.07% | +9.8% |
| Q2 2022 | $1,395,000 | +48.7% | 16,501 | +54.3% | 0.06% | +74.3% |
| Q1 2022 | $938,000 | +990.7% | 10,693 | +1080.2% | 0.04% | +775.0% |
| Q4 2020 | $86,000 | -67.8% | 906 | -69.0% | 0.00% | -78.9% |
| Q2 2019 | $267,000 | +6.0% | 2,925 | +11.4% | 0.02% | 0.0% |
| Q1 2019 | $252,000 | +12.0% | 2,626 | 0.0% | 0.02% | +11.8% |
| Q4 2018 | $225,000 | +2.3% | 2,626 | +3.0% | 0.02% | +6.2% |
| Q3 2018 | $220,000 | -0.5% | 2,549 | -6.6% | 0.02% | -11.1% |
| Q1 2018 | $221,000 | – | 2,729 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |